Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

869
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
869
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

312
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
312
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

580
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
580
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

531
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
531

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adipose Tissue Memory and Why Patients Regain Weight after Weight Loss: Understanding the Immunologic Basis for Recurrent Cardiovascular Risk.

Cardiology in review·2026
Same author

Nonocclusive Mesenteric Ischemia in Cardiogenic Shock: Mechanisms of Splanchnic Hypoperfusion and Strategies for Early Detection.

Cardiology in review·2026
Same author

Risk stratification for sudden cardiac death in nonischemic dilated cardiomyopathy: a moving target?

Frontiers in cardiovascular medicine·2026
Same author

Understanding Dysfunctional Autophagy and Mitophagy in Inflammatory Cardiovascular Disease.

Cardiology in review·2026
Same author

The Cardiopulmonary Complications of Vaping.

Cardiology in review·2026
Same author

Transplant Allograft Markers of Rejection for Heart, Liver, and Kidney Transplantation: A Review.

Cardiology in review·2026
Same journal

Finerenone and Cardiorenal Outcomes: A Narrative Review.

Cardiology in review·2026
Same journal

Role of Polypeptide Procalcitonin in Cardiac and Microvascular Injury in Sepsis, Myocardial Ischemia/Reperfusion, Cardiac Arrest, Mixed Shock, and Stress.

Cardiology in review·2026
Same journal

Do Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Predict In-Hospital and Long-Term Mortality in Endocarditis Patients?: A Systematic Review and Meta-Analysis.

Cardiology in review·2026
Same journal

Pacing for Pressure: The Clinical Efficacy of AVIM Therapy in Hypertension Management.

Cardiology in review·2026
Same journal

Venopulmonary Extracorporeal Membrane Oxygenation: Overview, Applications, and Current Evidence.

Cardiology in review·2026
Same journal

Women in Heart Failure With Preserved Ejection Fraction Clinical Trials: Bridging the Gap Between Trial Enrollment and Real-World Disease Burden.

Cardiology in review·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
07:35

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

2.3K

Microplastics: A Modifiable Cardiac Risk Factor.

Michael Kaiser1, Elena Tran1, Manish A Parikh1,2

  • 1From the Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY.

Cardiology in Review
|January 13, 2026
PubMed
Summary
This summary is machine-generated.

Microplastic exposure is linked to cardiovascular disease, potentially increasing risks for heart attack, stroke, and death. Identifying and mitigating microplastics could offer a new way to reduce cardiovascular disease risk.

Keywords:
NF-kBangiotensin IIatherosclerosiscardiovascular diseaseendothelial dysfunctionenvironmental cardiologyinflammationmicroplasticsnanoplasticsnitric oxideplastic pollution

More Related Videos

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
10:37

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

7.3K
Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
08:22

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

8.6K

Related Experiment Videos

Last Updated: Jan 14, 2026

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
07:35

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

2.3K
Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
10:37

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

7.3K
Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
08:22

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

8.6K

Area of Science:

  • Environmental Science
  • Cardiology
  • Toxicology

Background:

  • Cardiovascular disease is a leading cause of death globally.
  • Traditional risk factors do not capture all contributing elements.
  • Microplastic pollution is a growing environmental concern.

Purpose of the Study:

  • To review the literature on microplastic exposure.
  • To discuss the clinical implications of microplastics for cardiovascular disease.

Main Methods:

  • Literature review of experimental and clinical studies.
  • Analysis of microplastic effects on cardiovascular health markers.

Main Results:

  • Microplastics induce oxidative stress, inflammation, and cardiotoxicity.
  • Microplastics have been found in human coronary and carotid plaques.
  • Patients with microplastics in carotid plaques show a 4.5-fold increased risk of major adverse cardiovascular events.

Conclusions:

  • Microplastic exposure is associated with cardiovascular disease.
  • Microplastics represent a potential modifiable risk factor for cardiovascular disease.
  • Further research is needed to understand the full clinical impact.